Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model.
about
Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice.Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation.Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.Lipid-Drug Conjugate for Enhancing Drug Delivery.The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance.Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis
P2860
Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Stearoyl gemcitabine nanoparti ...... enopausal breast cancer model.
@en
type
label
Stearoyl gemcitabine nanoparti ...... enopausal breast cancer model.
@en
prefLabel
Stearoyl gemcitabine nanoparti ...... enopausal breast cancer model.
@en
P2093
P2860
P356
P1476
Stearoyl gemcitabine nanoparti ...... enopausal breast cancer model.
@en
P2093
Dharmika S P Lansakara-P
Jorge M Blando
Matthew G Hogan
Michael A Sandoval
Rebecca E De Angel
Sarah M Dunlap
Stephen D Hursting
Zhengrong Cui
P2860
P304
P356
10.4161/CBT.23623
P577
2013-01-28T00:00:00Z